Impact on non-motor symptoms, cognition, and QoL after 1-year of DBS for Parkinson’s Disease: An interim report from the ADROIT NAPA sub-study
Objective: To present the impact on cognition, quality of life, and non-motor symptoms after 1-year of DBS for Parkinson’s Disease through the ADROIT post-market study.…Validation of the English version of the Parkinson Anxiety Scale in the Canadian population: Interim results
Objective: To validate the use of the English version of the PAS in Parkinson’s disease (PD) patients in Canada. Background: The PAS, originally developed to…Assessment of non-motor symptoms of Parkinson’s disease in the long-term follow-up after the cell therapy
Objective: To evaluate the results of the introduction of MSCs on the non-motor symptoms in patients with PD within 12 months after the cell therapy.…Frequency of non- motor symptoms in dystonia patients
Objective: Our aim was to see a frequency of non-motor symptoms (NMS) in dystonia patients and influence on quality of life (QoL). Background: Non-motor problems…Factors that negatively impact the sexual function of women living with Parkinson’s disease
Objective: To investigate the impact of motor and non-motor alterations and couple adjustment on sexual function in women living with PD in Brazil. Background: Among…DNMSQuest: a simple tool for identifying mood disorders in cervical dystonia?
Objective: To compare DNMSQuest scores with validated measures of mood disorder in cervical dystonia patients attending a hospital botulinum toxin clinic. We wished to determine…Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update
Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…Subclinical inflammation and Parkinson’s disease
Objective: To investigate subclinical inflammation in individuals with early drug-naive Parkinson’s disease (PD). Background: Neutrophil-to-lymphocyte ratio (NLR) is used as a marker of subclinical inflammation.…“I’ve got cataracts and can’t read the information sheet about the medication you have given me”*
Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…Disentangling prodromal from non-prodromal symptoms of Parkinson’s disease
Objective: To define a subset of Parkinson’s disease (PD) symptoms that are present in both individuals with early PD and prodromal PD, compared with age-matched…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 51
- Next Page »